CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Nova Scotia Health Authority

John MacIsaac, MEd, B Tech, Manager Emergency Preparedness Projects & Planning

Patient-Centered Evolution of Medical Transport

John MacIsaac

John MacIsaac MEd

John (J.J.) MacIsaac MEd, B Tech, Advanced Care Paramedic, is the Nova Scotia Health Emergency Preparedness Manager—Projects and Planning. He previously worked for over 25 years as an Advanced Care Paramedic in the Emergency Health Services System for the province of Nova Scotia. In addition to his role with Nova Scotia Health, J.J. serves as the Director of Professional Development for the International Association of Emergency Managers (IAEM)— Canada Council.


Through this article MacIsaac talks about the evolution of medical transport systems. He contrasts the early days of simple transportation with the current sophisticated approach that emphasizes patient-specific care, specialized teams and expanded scope of practice for field providers.


I began my paramedic career in the early 1990's at a time when the prehospital system in my  home province of Nova Scotia consisted of a variety of ambulance operators, which included  those affiliated with funeral homes, taxi companies and the old adage "you call, we haul"  epitomized the straightforward approach of medical transport. Historically, this phrase reflected  a time when the primary role of emergency medical services (EMS) was to transport patients to  the nearest hospital as quickly as possible. However, the healthcare system's technological advancements have rendered this simplistic model obsolete. This culture shift is thanks to many  visionaries like Dr. Ron Stewart, a key player in modernizing EMS systems across North  America and highly influential globally. Today's medical transport systems embody a more  nuanced and sophisticated approach, emphasizing patient-specific care, efficient resource  allocation, and innovative treatment modalities. 


Medical transport systems have diversified significantly, embracing the value of specialized  teams tailored to suit patients' clinical requirements and the importance of ensuring that finite  resources are effectively used to support the community. Critical care transport teams, for  instance, are equipped with advanced training and resources crucial for patients requiring  intensive monitoring and intervention, ensuring they receive the same level of attention during  transport as they would in a hospital setting. 


Conversely, there is growing recognition of the need for low-risk transport services for stable  patients. Efficient management of non-emergency transport services helps alleviate the burden  on emergency systems, ensuring that ambulances and other care resources are reserved for those in need. This stratification of transport services underscores a broader trend in healthcare:  prioritizing resource allocation based on patient acuity and necessity. 


A significant factor in the modernization of medical transport is the expanded scope of practice  for field providers. Paramedics and other community healthcare providers are now trained to  perform a wider range of procedures with opportunities to collaborate in making appropriate  patient care and disposition decisions. By enhancing the capabilities of field providers, medical  transport services can deliver more effective and immediate care, improving patient outcomes  and reducing the need for hospital admissions. 


In addition to these advancements, integrating virtual care options represents a transformative  shift in medical care. Alternate treatment pathways reduce unnecessary transports by enabling  patients to receive appropriate care without travelling. For example, patients with chronic  conditions can be assessed and managed virtually, with local healthcare teams providing directed interventions guided by specialist clinicians. This approach enhances patient convenience and  comfort while ensuring transport resources are available for those in need. 


In conclusion, the landscape of medical transport has evolved far beyond the simplistic "you call,  we haul" mentality. Modern systems are characterized by specialized teams, an expanded scope  of practice for field providers, and the innovative use of virtual care. These advancements ensure  patient care is tailored to individual needs, resources are utilized efficiently, and unnecessary  transports are minimized. As healthcare evolves, medical transport services must remain  adaptive, embracing new technologies and practices to provide the highest standard of care in an  ever-changing environment.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/john-macisaac-nwid-2850.html